Irving Investors

Navan provides a travel, expense, and corporate card management platform that automates manual processes and enhances spend visibility. The platform combines cloud, mobile, and AI capabilities to streamline business travel and expense management, offering automated booking tools, integrated expense reporting, real-time visibility, and configurable controls. It serves corporate employees, finance teams, and travel managers to simplify travel, reduce administrative overhead, and ensure budget compliance while aligning with policy standards.

Caris Life Sciences specializes in advanced molecular profiling technologies for cancer diagnostics and drug development. Established in 1987, it offers prognostic testing services, genomic profiling, and clinico-genomic data platforms to improve patient outcomes. The company operates globally with offices in the US and Switzerland.

CoreWeave is a company that specializes in developing a cloud infrastructure platform aimed at providing powerful computing resources for artificial intelligence/machine learning (AI/ML) projects and other initiatives. Their platform features a specialized GPU cloud system designed to accelerate workflows by matching the complexity of models, allowing clients to scale efficiently and adapt to rapidly changing compute requirements. This enables clients to design and innovate with various types of compute resources tailored to their specific needs.

OpenAI is an AI research and deployment company that develops general-purpose artificial intelligence technologies and applies them to real-world problems. It conducts machine learning research and builds systems such as large-scale language models, multimodal input handling, and code generation to support automation, data analysis, content generation, and interactive problem solving across industries including technology, healthcare, and education. The organization offers platforms and APIs that enable enterprises, developers, and researchers to build, test, and deploy intelligent systems, with plug-in extensibility and ongoing model updates to improve performance and safety.

Turo Inc. is an online car rental marketplace that connects local car owners with travelers seeking to rent vehicles. Founded in 2009 and based in San Francisco, California, Turo allows users to list their cars for rent, offering options for local pickup, city delivery, and airport delivery. The platform provides a wide selection of vehicles at competitive prices, enabling car owners to earn income while providing convenient access to cars for renters. Turo facilitates a peer-to-peer car-sharing model, creating a vibrant community of trusted hosts and enhancing the travel experience for users. The company was formerly known as RelayRides, Inc. before rebranding in November 2015.

Attentive is a leading provider of conversational commerce solutions, specializing in a personalized mobile messaging platform that enhances business-to-consumer communication. The company enables brands and organizations to engage with customers using behavioral data, allowing for the automatic delivery of tailored mobile messages throughout the customer lifecycle. This includes functionalities such as product recommendations, limited-time sales, payment processing, and real-time customer service. By focusing on SMS as a primary channel, Attentive helps e-commerce and retail businesses forge stronger connections with mobile shoppers, transforming the way they interact and communicate with their audiences.

OneTrust, LLC is a technology company that specializes in privacy management and compliance solutions. Founded in 2016 and headquartered in Atlanta, Georgia, the company offers a comprehensive platform that automates various aspects of privacy program management, including privacy impact assessments, data inventory mapping, and risk remediation actions. OneTrust’s solutions facilitate compliance with global regulations by providing tools for vendor risk management, incident reporting, and website compliance, as well as managing data subject rights and consent. The platform serves a diverse clientele ranging from multinational corporations to small and medium enterprises, allowing them to collaborate effectively on privacy risks associated with customer, employee, and vendor data. OneTrust also provides training and certification programs, ensuring that organizations can maintain continuous compliance through ongoing audits and assessments. With additional offices worldwide, OneTrust is positioned to support businesses in navigating the complexities of privacy regulations across various sectors and jurisdictions.

Databricks offers a unified data analytics platform that simplifies data integration, enables real-time experimentation, and facilitates robust deployment of production applications for developers and data scientists. Serving diverse industries worldwide, Databricks' platform supports collaborative data science, machine learning workflows, and integrates with various cloud services.

Celonis is a company that specializes in execution management, focusing on optimizing and analyzing business processes across various industries, including production, human resources, and logistics. Its core product, the Celonis Execution Management System (EMS), utilizes advanced process mining technology to enhance productivity and streamline operations. The EMS provides a comprehensive suite of tools and applications, including Celonis Studio, designed for business executives and users to effectively manage execution across analytics, strategy, planning, and automation. By offering unique software solutions, Celonis enables organizations to improve process transparency and efficiency, ultimately unlocking their full execution capacity.

Icertis is a cloud-based enterprise contract management platform that streamlines complex contract processes. Founded in 2009, it helps businesses accelerate growth by improving contract velocity, safeguard against risks through regulatory compliance, and optimize commercial relationships to maximize revenue.

Snyk Ltd., established in 2015, specializes in a Software as a Service (SaaS) platform that enhances application security. It focuses on identifying, rectifying, and monitoring known vulnerabilities across critical components of modern applications, including code, open-source libraries, containers, and infrastructure as code. Snyk's offerings, such as Snyk Code (static application security testing), container vulnerability management, and application security management, integrate seamlessly with developers' workflows, improving security posture, productivity, and collaboration. With over 1,200 global customers, including industry leaders like Google and Salesforce, Snyk is recognized for its developer-first approach and strategic partnerships.

Chainalysis designs and develops anti-money laundering software for cryptocurrency businesses and financial institutions. Its platform offers REACTOR, an interactive investigation tool that identifies offenders, visualizes data, and shares results; Kryptos, a risk assessment tool for understanding cryptocurrency activity and investment opportunities; and an API that provides transaction-based risk scoring with source and destination of funds. The company also provides activity monitoring reports, due diligence tools, and cyber threat intelligence derived from the deep web to help analysts estimate criminal revenues and identify emerging threats. Additional offerings include real-time API access and web-based investigation software for due diligence and customer verification, as well as tools to identify cyber criminals and attribute cyber threats. Chainalysis serves government agencies, banks, exchanges, insurance firms, and other cryptocurrency businesses. Founded in 2014 and headquartered in New York, it maintains offices in Copenhagen, Tokyo, and Singapore.

Founded in 2012 and headquartered in Boston with a London office, Klaviyo is a marketing automation platform specializing in email marketing for eCommerce businesses. It offers personalized newsletters, automated emails like abandoned cart reminders, and integrates natively with customer data sources.

Leap Services, Inc., established in 2018 and based in Chicago, Illinois, specializes in branded retail. It operates a platform that enables brands to set up stores in optimal locations, securing favorable terms. Leap also manages retail stores for consumer brands in major U.S. cities, offering a comprehensive service that covers store development, staffing, and technology infrastructure. By utilizing data-driven insights and a technology-enabled approach, Leap aims to make physical retail more productive and less risky for brands, driving growth and enhancing customer experience.

Metagenomi, Inc. is a genetic medicines company focused on developing innovative gene editing systems to address genetic diseases. Incorporated in 2016 and headquartered in Emeryville, California, Metagenomi utilizes metagenomics and machine learning to discover novel genome editing technologies. By sourcing cellular machinery from previously uncharacterized organisms, the company creates a proprietary toolbox that includes programmable nucleases, base editors, and advanced integration systems like prime editing and CRISPR-associated transposases. These systems are designed to be ultra-small, efficient, and highly specific, minimizing the risk of immune responses. Metagenomi aims to revolutionize gene editing techniques and deliver curative therapeutics to patients worldwide.

Checkr is a technology company that builds platforms for the background check industry. It provides screening services such as social security number trace, criminal record checks, driving records, verifications, drug tests, and credit checks, along with continuous monitoring and security infrastructure. The company offers an API and Checkr Connect IDV to integrate identity verification with background checks, enabling faster and more transparent hiring decisions. It serves multiple sectors, including financial services, retail and hospitality, healthcare, higher education, on-demand economy platforms, manufacturing, software and technology, and contact centers and peer-to-peer marketplaces. Founded in 2014, Checkr is headquartered in San Francisco.

Arctic Wolf Networks offers cloud-native security operations technology, providing Managed Detection and Response, Managed Risk, and Managed Cloud Monitoring services. Its team of concierge security engineers acts as an extension of clients' internal teams, offering tailored threat detection, response, and ongoing risk management to protect valuable business data.

DNA Script is a Paris-based company that develops synthetic biology tools focused on DNA synthesis. It employs enzymatic processes to produce synthetic nucleic acids, including oligonucleotides, enabling genomics and molecular biology applications. Founded in 2014, it introduced the SYNTAX benchtop DNA printer to provide labs with greater workflow control and faster access to results. By producing DNA through natural enzymes, the company aims to accelerate research and the development of new therapeutics.

Bombas is a New York-based apparel brand established in 2013, specializing in the manufacture and online sale of premium athletic socks for men, women, teens, and girls. The company is committed to producing high-quality, comfortable, soft, and durable socks at affordable prices. Notably, Bombas donates one pair of socks to homeless shelters for every pair sold, demonstrating its dedication to helping those in need.

Shoreline Biosciences, Inc. is a biotechnology company based in La Jolla, California, founded in 2020. The company specializes in developing cell-based immunotherapies aimed at treating seriously ill patients. Shoreline's proprietary technology platform leverages advanced methods in induced pluripotent stem cell (iPSC) differentiation and genetic programming, specifically targeting the IL-15/CISH pathway. This approach enhances the metabolic fitness and persistence of engineered natural killer (NK) cells, improving their anti-cancer activity. Shoreline's focus includes creating clinically effective immunotherapies using iPSC-derived NK cells and macrophages, providing innovative and cost-effective treatment options for oncology and other serious health conditions.

InterVenn is a life science company focused on revolutionizing healthcare through the study of glycoproteomics, which involves glycosylated proteins that significantly influence protein function. By developing an innovative AI-powered platform, InterVenn decodes the complex glycoproteome, providing critical biological insights that were previously unattainable. This technology enables the identification, quantification, and classification of glycoproteomic signals in human blood and tissue, facilitating early detection and triaging of cancers, particularly ovarian cancer. InterVenn’s platform supports the creation of a diverse range of clinical applications, from disease screening to diagnostics, and has the potential to contribute to therapeutics. Founded by renowned experts, including Nobel Laureate Dr. Carolyn Bertozzi, InterVenn aims to advance personalized, predictive, and preventative healthcare solutions, enhancing patient outcomes and aiding pharmaceutical partners in their research and development efforts.

Genomatica, Inc. is a biotechnology company based in San Diego, California, specializing in the development of manufacturing processes for intermediate and basic chemicals derived from renewable feedstocks. Founded in 1998, the company utilizes its proprietary biotechnology platform to create fermentation-based processes and to engineer microorganisms that facilitate the conversion of these feedstocks into essential chemicals. Genomatica has successfully commercialized processes for chemicals such as butanediol, which is used in biodegradable plastics and apparel, and butylene glycol, commonly found in cosmetics and personal care products. The company is also actively working on bio-nylon and has developed a pipeline targeting the production of 20 different chemicals. Recognized for its innovative technologies, Genomatica has received numerous accolades, including the Kirkpatrick Award for outstanding chemical engineering technology and the ICIS Innovation Award for its Brontide butylene glycol.

Cybereason is a cybersecurity company that provides an endpoint protection and response platform designed to detect, block, investigate, and respond to advanced cyber threats. Its platform combines modules such as Deep Detect & Respond, Deep Prevent, Deep Investigate, Deep Respond, and an anti-ransomware tool called RansomFree. The system uses an automated in-memory graph to identify behavioral patterns across endpoints and reveal the full attack campaign, enabling rapid root-cause analysis and shutdown of threats. The company also offers monitoring, investigation, hunting, analysis, deployment, and training services. Cybereason was founded in 2012 and is based in Boston, with offices in London, Tel Aviv, Tokyo, and Sydney.

BioTheryX, Inc. is a clinical-stage biopharmaceutical company based in Chappaqua, New York, that specializes in restoring protein homeostasis through innovative small molecule therapies. The company develops Protein Homeostatic Modulators, including a small molecular glue that targets cereblon for protein degradation, with applications in oncology, inflammation, and other diseases. BioTheryX employs its proprietary PRODEGY platform, which utilizes a library of cereblon binders to design targeted protein degraders (TPDs). Among its key products is BTX-A51, an oral multi-kinase inhibitor aimed at treating specific leukemic stem cell targets and preventing the transcription of oncogenic genes. Founded in 2007, BioTheryX aims to address unmet medical needs by leveraging its expertise in targeted protein degradation.

LUMICKS develops innovative technologies for studying biology and cancer at single-molecule and single-cell levels. Its products include C-Trap Optical Tweezers, Fluorescence Microscopy, and z-Movi Cell Avidity Analyzer, enabling real-time analysis of complex biological processes and interactions.

Crossover Health designs and delivers workplace healthcare services for employers and employees, offering primary care and a broad range of ancillary and advanced services, including urgent and preventive care, chronic disease management, health risk assessment, health education, coaching, biometrics, physical therapy, chiropractic, acupuncture, care coordination, health analytics, and remote care. It operates as a primary care medical group that blends health management services with technology-enabled tools to create a comprehensive employee care experience. Founded in 2010 and based in California, Crossover Health serves client organizations through on-site and partner health centers across Silicon Valley and other U.S. locations, with a focus on improving access to care, enhancing member experience, and reducing healthcare costs for employers and their workforce.

Absci is a drug and target discovery company that leverages deep learning AI and synthetic biology to enhance the therapeutic potential of proteins. Its Integrated Drug Creation Platform streamlines the process of identifying novel drug targets, discovering optimal biotherapeutic candidates, and generating the necessary cell lines for manufacturing. By combining biologic drug discovery and cell line development into a single, efficient workflow, Absci collaborates with biotech and pharmaceutical innovators to develop next-generation protein-based drugs. These innovations include Bionic Proteins, which feature nonstandard amino acids, and other unique drug designs that may be unattainable through conventional methods. Absci's mission is to facilitate the development of improved medicines by effectively translating innovative ideas into viable drugs.

Egenesis Inc. is a biotechnology company focused on gene editing and genome engineering to create human transplantable organs, tissues, and cells. Established in 2015 and headquartered in Cambridge, Massachusetts, with an additional office in New York City, Egenesis aims to address the global organ shortage by developing solid organs and therapeutic cell transplantation solutions for various diseases. The company utilizes a gene editing platform that incorporates techniques such as single-cell cloning and somatic cell nuclear transfer, which are essential for creating human-compatible organ tissues and cells. Egenesis is particularly engaged in advancing programs related to kidney and islet cell transplantation, striving to provide alternative treatment options for patients with life-threatening conditions.

Model Medicines is a biotechnology company that specializes in drug discovery through the integration of human expertise and artificial intelligence. Utilizing its ActivPred AI Drug Discovery Platform, Model Medicines accelerates the identification of potential therapeutics that can be repositioned to address significant health challenges. The company focuses on a diverse pipeline of patent-pending drugs targeting various conditions, including oncology, infectious diseases, neurological disorders, and gastric disorders. By leveraging advanced AI and machine learning techniques, Model Medicines aims to streamline the drug development process, enabling new treatments to enter clinical trials within months. Its innovative approach positions the company to significantly impact the pharmaceutical landscape by delivering life-changing therapies at scale.

NexImmune, Inc. is a clinical-stage biopharmaceutical company based in Gaithersburg, Maryland, focused on developing innovative immuno-therapeutics utilizing its proprietary Artificial Immune (AIM) technology. Founded in 2011, the company aims to enhance the immune system's response to various diseases, including cancer, inflammation, viral infections, transplant rejection, and autoimmunity. NexImmune's lead product candidates are AIM101, an aAPC-based injectable therapy targeting specific solid tumors, and AIM ACT, an adoptive cellular therapy for hematological malignancies. The AIM technology facilitates a controllable and reproducible immune response by leveraging the body's T cells to initiate targeted actions against specific antigens, even in conditions where natural antigen presenting cells are compromised. Currently, NexImmune is advancing its therapies through clinical trials, including NEXI-001 for acute myeloid leukemia and NEXI-002 for multiple myeloma.

Imago BioSciences, Inc. is a clinical-stage biotechnology company based in Redwood City, California, founded in 2012. The company specializes in developing novel small molecule therapeutics aimed at treating hematologic diseases, including myelodysplastic syndromes, acute myelogenous leukemia, and other conditions associated with bone marrow failure. Central to its research is the enzyme lysine-specific demethylase 1 (LSD1), which is involved in the regulation of blood cell production. Imago BioSciences is focused on translating advanced scientific insights into transformative therapies that can alter the course of disease, thereby enhancing the quality and longevity of life for patients. Its lead product candidate, Bomedemstat, is an orally administered LSD1 inhibitor currently under evaluation for its potential to modify disease progression in patients with myeloproliferative neoplasms, a group of chronic bone marrow cancers.

Prometheus Biosciences, established in 1995 and headquartered in San Diego, California, specializes in developing and commercializing innovative pharmaceutical and diagnostic products. The company's portfolio includes tests that enable physicians to provide personalized patient care, such as monitoring drug and anti-drug antibody levels, diagnosing and prognosticating inflammatory bowel disease (IBD), and detecting celiac disease and lactose intolerance. Prometheus also offers therapeutic products like Entocort EC for treating Crohn's disease and has agreements to develop and market other drugs. The company's commitment to innovation positions it as a leader in precision healthcare, particularly in gastroenterology.

Nuvation Bio Inc. is a biopharmaceutical company dedicated to addressing unmet needs in oncology through the development of novel therapies for challenging cancers. Founded in 2018 and headquartered in New York, with an additional office in San Francisco, Nuvation Bio focuses on treating patients whose conditions have not responded to conventional treatments. The company's leading clinical-stage candidate, NUV-868, is a BD2-selective oral small molecule BET inhibitor that targets the BRD4 protein, which plays a crucial role in regulating tumor growth and differentiation. In addition to NUV-868, Nuvation Bio is advancing a proprietary small molecule Drug-Drug Conjugate platform aimed at enhancing therapeutic efficacy. The company’s comprehensive portfolio includes multiple drug development candidates designed to meet the specific needs of cancer patients.

Praxis Precision Medicines is a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system disorders marked by neuronal imbalance. Established in 2015 and headquartered in Cambridge, Massachusetts, the company leverages genetic insights to create innovative treatments for neurological and psychiatric conditions. Its leading product candidates include PRAX-114, an allosteric modulator targeting GABAA receptors, currently undergoing Phase IIa trials for major depressive disorder and perimenopausal depression, and PRAX-944, a selective inhibitor of T-type calcium channels in Phase IIa trials for essential tremor. Additionally, Praxis is advancing PRAX-562, a sodium current blocker in Phase I trials for severe pediatric epilepsy and adult cephalgia, along with PRAX-222, an antisense oligonucleotide aimed at treating patients with SCN2A epilepsy, and a program focused on KCNT1-related epilepsy. The company has established collaborations and licensing agreements with various organizations to enhance its research and development efforts.

Goldfinch Bio, Inc. is a clinical-stage biotechnology company based in Cambridge, Massachusetts, dedicated to discovering and developing precision therapies for patients with kidney diseases. The company focuses on conditions such as focal segmental glomerulosclerosis, diabetic nephropathy, and polycystic kidney disease. Key product candidates include GFB-887, a selective inhibitor of the TRPC5 channel, and GFB-024, a cannabinoid receptor 1 inverse agonist. Goldfinch Bio integrates advancements in kidney genetics and biology through its Kidney Genome Atlas, a genomic registry that aids in identifying new disease targets and biomarkers. Additionally, the company employs stem cell science to create human organoid models, which facilitate the validation of novel therapeutic targets. Goldfinch Bio has established a strategic collaboration with Gilead Sciences to further enhance its research and development efforts. Founded in 2016, Goldfinch Bio aims to transform the treatment landscape for progressive kidney disease.

Rubrik provides data security solutions to organizations worldwide, offering live data access for recovery and application development. Its platform combines enterprise data management with web-scale IT, eliminating backup software and enabling businesses to manage data across private and public clouds within minutes.

Rebel Foods is a prominent operator of cloud kitchens that specializes in delivering food on demand through a variety of in-house brands. The company combines culinary expertise with advanced technology to ensure high food quality and efficient delivery. Its innovative approach includes the use of dark kitchens, which allow for streamlined operations and expanded menu options. Rebel Foods offers a range of food brands catering to different consumer dining occasions, including the well-known FAASOS brand, which focuses on retail food provision and home delivery services. By prioritizing ingredient sourcing and preparation standards, Rebel Foods aims to enhance the overall dining experience for food enthusiasts.

ThredUp Inc. is an online consignment and thrift store specializing in the resale of women's and children's apparel, shoes, and accessories. Founded in 2009 and headquartered in Oakland, California, ThredUp operates one of the largest resale platforms globally, promoting a sustainable shopping model by making it easy for consumers to buy and sell secondhand items. The company generates revenue through sales on its website and mobile app, as well as partnerships with retail-as-a-service providers. With a mission to encourage consumers to prioritize secondhand shopping, ThredUp aims to extend the life cycle of clothing and transform the fashion industry towards a more sustainable future.

ORIC Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing innovative therapies to combat cancer by overcoming resistance mechanisms. The company's lead product candidate, ORIC-101, is a small molecule antagonist of the glucocorticoid receptor, which plays a significant role in resistance to various cancer treatments across multiple solid tumors. Another key candidate, ORIC-533, is an orally bioavailable inhibitor of CD73, targeting a critical pathway in the adenosine metabolism that contributes to resistance against chemotherapy and immunotherapy. Additionally, ORIC is working on a pipeline of precision medicines aimed at addressing other cancer resistance mechanisms. Founded in 2014 and headquartered in South San Francisco, California, ORIC Pharmaceuticals leverages the expertise of its scientific founders, who have extensive backgrounds in cancer research and target discovery.

Rebel Foods is a prominent operator of cloud kitchens that specializes in delivering food on demand through a variety of in-house brands. The company combines culinary expertise with advanced technology to ensure high food quality and efficient delivery. Its innovative approach includes the use of dark kitchens, which allow for streamlined operations and expanded menu options. Rebel Foods offers a range of food brands catering to different consumer dining occasions, including the well-known FAASOS brand, which focuses on retail food provision and home delivery services. By prioritizing ingredient sourcing and preparation standards, Rebel Foods aims to enhance the overall dining experience for food enthusiasts.

Foghorn Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing innovative medicines that target genetically determined dependencies within the chromatin regulatory system. Utilizing its proprietary Gene Traffic Control platform, Foghorn aims to manipulate gene expression to develop therapies for cancer and other serious diseases. The company is advancing multiple drug candidates, including FHD-286, a small-molecule enzymatic inhibitor designed for treating acute myeloid leukemia and uveal melanoma, and FHD-609, a protein degrader targeting BRD9 for synovial sarcoma. Additionally, Foghorn is engaged in preclinical and discovery programs that focus on selectively targeting BRM in non-small-cell lung cancer and developing modulators for ARID1B in bladder, ovarian, and endometrial cancers. Founded in 2015 and headquartered in Cambridge, Massachusetts, Foghorn Therapeutics collaborates with Merck Sharp & Dohme Corp. to explore novel oncology therapeutics.

Pearl Health, established in 2019 and headquartered in West Hollywood, California, specializes in developing artificial intelligence (AI) tools for the dentistry industry. The company offers a suite of products, including Second Opinion, a computer vision platform that identifies dental pathologies; Smart Margin, aiding in dental restoration; Scan Clarity Score, evaluating patient scan quality; and Practice Intelligence, providing office-specific data for decision-making. Pearl's AI technology, cleared by the FDA, recognizes and measures various dental issues, enabling practitioners, labs, and insurers to enhance efficiency, accuracy, and consistency in dental care.

PAX Labs, Inc. is a prominent manufacturer of loose-leaf vaporizers and accessories designed for dry herbs and concentrates. With a focus on innovation and premium design, PAX offers a range of products including the PAX 3, PAX 2, and PAX Era, alongside their related accessories. The company also provides an online mobile application to enhance user experience. Founded in 2004 and initially known as Ploom, Inc., PAX Labs rebranded in 2015 and has since established itself as a leader in the vaporization technology sector. Headquartered in San Francisco, California, PAX Labs distributes its products through a network of retailers and distributors in the United States and internationally, as well as via online platforms.

Dixie Brands is a leading producer of cannabis-infused products, established in 2010 following the legalization of medical marijuana in Colorado. The company specializes in crafting a variety of premium items, including sparkling beverages, edibles, sublingual tinctures, concentrates, topicals, and formulations that combine CBD and THC. Dixie Brands is committed to safety and quality, ensuring that all products are infused with CO2-extracted THC and undergo rigorous triple lab testing. With a mission to be a trusted source in the cannabis industry, Dixie Brands emphasizes innovation, research, education, and advocacy in its operations. The company has distinguished itself by being the first to obtain an Infused Products Retail Marijuana License, reflecting its leadership in the market for medical marijuana-infused products.

GOAT Group, established in 2015, operates a global marketplace for authentic sneakers, apparel, and accessories. It offers products from over 350 brands through its GOAT and Flight Club platforms, available in physical stores and online. GOAT Group has 13 retail locations worldwide, serving customers in 170 international markets. The company's innovative technology ensures product authenticity, providing trust to its 20 million members across 164 countries. GOAT Group is backed by strategic investors and venture capital firms, including Foot Locker, Inc.

Rumble Fitness, LLC specializes in boxing-inspired fitness classes, combining elements of high-intensity interval training, strength training, and metabolic conditioning. Founded in 2016 and based in New York, the company offers a unique workout experience centered around specially designed water-filled boxing bags, set to a curated mix of hip-hop and house music. In addition to fitness classes, Rumble sells boxing-related products such as gift cards, wraps, gloves for rental, and bottled water online. The focus is on helping individuals achieve a lean and strong physique while promoting overall health and fitness.

Anaplan, Inc. offers a cloud-based connected planning platform that enables organizations to unify disparate data structures across various business functions, including finance, sales, supply chain, marketing, human resources, and operations. Founded in 2008 and headquartered in San Francisco, Anaplan provides its services through a subscription model, allowing users to access its platform over the Internet. The company focuses on enhancing decision-making and collaboration within organizations by delivering business planning and performance management solutions from a single hub. In addition to its core platform, Anaplan offers professional services, including consulting, implementation, training, and planning transformation advisory services. With operations in multiple countries and a network of expert partners, Anaplan supports large and fast-growing organizations in streamlining their planning processes and making informed decisions.

Bombas is a New York-based apparel brand established in 2013, specializing in the manufacture and online sale of premium athletic socks for men, women, teens, and girls. The company is committed to producing high-quality, comfortable, soft, and durable socks at affordable prices. Notably, Bombas donates one pair of socks to homeless shelters for every pair sold, demonstrating its dedication to helping those in need.

GOAT Group, established in 2015, operates a global marketplace for authentic sneakers, apparel, and accessories. It offers products from over 350 brands through its GOAT and Flight Club platforms, available in physical stores and online. GOAT Group has 13 retail locations worldwide, serving customers in 170 international markets. The company's innovative technology ensures product authenticity, providing trust to its 20 million members across 164 countries. GOAT Group is backed by strategic investors and venture capital firms, including Foot Locker, Inc.

GOAT Group, established in 2015, operates a global marketplace for authentic sneakers, apparel, and accessories. It offers products from over 350 brands through its GOAT and Flight Club platforms, available in physical stores and online. GOAT Group has 13 retail locations worldwide, serving customers in 170 international markets. The company's innovative technology ensures product authenticity, providing trust to its 20 million members across 164 countries. GOAT Group is backed by strategic investors and venture capital firms, including Foot Locker, Inc.

Instacart operates a grocery delivery platform in the United States and Canada, partnering with local and national grocers to offer a broad catalog of items for home delivery. Customers can mix items from multiple stores in a single order, and orders are picked and delivered by shoppers who are typically independent contractors. The platform supports fast delivery, including options in as little as an hour. Instacart earns revenue from service fees based on order value and by selling advertising to consumer-packaged goods brands. The service catalogs about 500,000 items and attracts about 8 million monthly active users, supported by roughly 600,000 shoppers.

Lyft is a transportation company that designs, markets, and operates a mobile application that connects riders with drivers for private and shared rides, with in-app payment and the ability to schedule trips in advance. The platform has expanded to multimodal options, including bike- and scooter-sharing, to provide integrated transportation options. Founded in 2013 and publicly listed in 2019, Lyft is the second-largest ride-sharing service provider in the United States and Canada, serving diverse user segments including college, university, and corporate communities.